safeti
immunogen
two
authent
recombin
ar
rift
valley
fever
rvf
virus
one
delet
nss
region
rna
segment
larg
delet
nsm
gene
pre
gn
region
rna
segment
rvf
vaccin
viru
test
crossbr
ewe
day
gestat
first
evalu
neutral
antibodi
respons
measur
plaqu
reduct
neutral
prnt
clinic
respons
two
virus
group
four
ewe
viru
dose
plaqu
form
unit
pfu
control
group
four
ewe
also
inocul
similar
dose
rvf
parent
recombin
viru
neutral
antibodi
first
detect
anim
inocul
day
post
inocul
four
anim
prnt
titer
day
neutral
antibodi
first
detect
ewe
inocul
day
prnt
titer
day
found
mean
prnt
respons
lower
ewe
inocul
rvf
abort
occur
though
singl
fetal
death
rvf
group
found
necropsi
poor
prnt
respons
caus
us
discontinu
test
candid
focu
dose
escal
studi
show
plaqu
form
unit
pfu
stimul
prnt
respons
compar
dose
pfu
viru
studi
viru
may
prove
safe
efficaci
candid
livestock
vaccin
larg
delet
nsm
gene
may
also
provid
neg
marker
allow
serolog
differenti
natur
infect
anim
vaccin
anim
test
recombin
rvf
vaccin
candid
day
pregnant
ewe
abort
fetal
abnorm
observ
candid
immunogen
safe
pregnant
ewe
dose
pfu
stimul
prnt
respons
compar
higher
dose
morril
et
al
rift
valley
fever
viru
rvfv
famili
bunyavirida
genu
phleboviru
segment
singlestrand
rna
viru
etiolog
agent
vectorborn
zoonot
diseas
rift
valley
fever
rvf
viru
pose
public
health
econom
threat
outbreak
signific
impact
affect
area
rvfv
genom
contain
three
rna
segment
negativesens
ambisens
polar
l
antiviralsens
lsegment
nt
encod
viral
rnadepend
rna
polymeras
antiviralsens
segment
nt
encod
two
major
envelop
glycoprotein
gn
gc
two
accessori
protein
nsm
nsm
protein
essenti
rvfv
replic
cell
cultur
wherea
rvfv
mutant
lack
pregn
region
less
pathogen
rvfv
carri
pregn
region
rat
indic
nsm
antiapoptosi
function
affect
viral
pathogen
segment
encod
nonstructur
protein
nss
major
virul
factor
nucleocapsid
n
protein
suscept
individu
rvfv
infect
presum
high
protect
achiev
humor
immun
respons
colostrum
singl
administr
vaccin
elicit
rapid
humor
respons
longterm
protect
immun
outbreak
scenario
would
save
live
fiscal
resourc
sever
rvfv
vaccin
develop
work
still
remain
improv
safeti
respons
effect
environment
stabil
genom
integr
long
term
immun
report
test
pregnant
ewe
two
recombin
virus
possess
delet
either
nss
region
nsm
region
rvf
genom
assess
safeti
immunogen
potenti
use
livestock
vaccin
healthi
suffolkrambouillet
crossbr
ewe
estru
synchron
timebr
day
gestat
time
vaccin
use
ewe
neg
rvfv
neutral
antibodi
plaqu
reduct
neutral
assay
time
vaccin
recombin
viru
ar
identifi
genet
ident
live
attenu
rvf
vaccin
prepar
salk
institut
swiftwat
pa
u
armi
medic
research
institut
infecti
diseas
usamriid
use
human
investig
new
drug
ind
applic
serv
recombin
viru
control
two
recombin
virus
test
safeti
immunogen
identifi
gener
revers
genet
techniqu
virus
contain
genom
viru
delet
nss
region
rna
segment
viru
larg
delet
nsm
gene
pre
gn
region
rna
segment
rvf
pregnant
ewe
hous
usda
approv
ag
biocontain
facil
ewe
random
test
group
acclim
biocontain
facil
day
studi
conduct
two
phase
phase
evalu
immunogen
safeti
two
recombin
virus
judg
promis
vaccin
candid
term
immunogen
safeti
phase
ii
test
escal
dose
safeti
immunogen
phase
group
ewe
inocul
subcutan
sc
approxim
plaqu
form
unit
pfu
recombin
viru
rvf
phase
ii
grade
dose
test
group
anim
ewe
examin
daili
veterinarian
train
veterinari
anim
specialist
whole
blood
collect
prior
inocul
day
day
inocul
day
daili
day
period
thereaft
day
rectal
temperatur
health
statu
document
daili
ewe
euthan
pentobarbit
sodium
mgkg
iv
prior
term
necropsi
perform
ewe
fetu
tissu
collect
viru
isol
histopatholog
examin
immunohistochemistri
ihc
fetal
crownrump
cr
measur
taken
estim
approxim
age
fetus
serum
harvest
whole
blood
store
c
specimen
select
organ
fix
formalin
process
histopatholog
ihc
examin
formalinfix
paraffinembed
tissu
section
stain
hematoxylin
eosin
h
e
rabbit
antin
antibodi
use
ihc
stain
homogen
wv
fresh
tissu
prepar
hank
balanc
salt
solut
hbss
ph
supplement
fetal
bovin
serum
antibiot
u
penicillin
streptomycin
sulfat
clarifi
low
speed
centrifug
store
c
viral
rna
extract
tissu
homogen
use
high
pure
viral
rna
extract
kit
roch
appli
scienc
indianapoli
usa
accord
manufactur
instruct
firststrand
cdna
synthes
superscript
ii
use
random
primer
invitrogen
carlsbad
ca
rtpcr
perform
platinum
taq
polymeras
invitrogen
use
follow
primer
set
aca
caa
agc
tcc
cta
gag
tgc
gtt
cgg
ctt
ctg
caa
gc
ssegment
detect
aca
caa
aga
cgg
tgc
att
act
gca
aag
ggc
aca
acc
tc
msegment
detect
use
serial
dilut
rtpcr
could
detect
sand
msegment
pfu
data
shown
follow
pcr
condit
use
min
follow
cycl
sec
sec
min
follow
final
min
extens
pcr
fragment
subsequ
analyz
agaros
gel
electrophoresi
viru
isol
neat
serum
tissu
homogen
accomplish
cultur
sampl
vero
cell
cm
flask
previous
describ
flask
observ
cytopath
effect
daili
day
blind
passag
fresh
vero
cell
viru
titer
determin
plaqu
assay
vero
cell
monolay
previous
describ
serum
neutral
antibodi
determin
use
plaquereduct
neutral
test
prnt
previous
describ
sera
test
rvfvspecif
igg
antibodi
use
enzym
immunoassay
previous
describ
sera
igg
test
initi
dilut
cutoff
valu
assign
posit
igg
result
determin
panel
five
sera
rvfv
igg
neg
anim
calcul
adjust
od
valu
greater
sd
calcul
done
use
prism
version
analysi
softwar
graphpad
softwar
inc
analysi
mean
prnt
titer
mean
serum
igg
valu
done
use
oneway
analysi
varianc
post
hoc
tukey
multipl
comparison
test
signific
level
phase
test
group
ewe
clinic
immunolog
respons
two
vaccin
candid
compar
recombin
parent
viru
individu
neutral
antibodi
respons
ewe
list
tabl
mean
prnt
respons
four
group
shown
figur
figur
show
serum
igg
respons
four
group
time
seroconvers
intens
neutral
antibodi
respons
markedli
delay
lesser
intens
group
compar
group
studi
mean
rectal
temperatur
group
exceed
data
shown
ewe
inocul
experienc
signific
advers
clinic
event
howev
ewe
pregnant
necropsi
ewe
singl
viabl
fetu
cr
measur
cm
ewe
viabl
twin
fetus
cr
measur
cm
respect
estim
three
fetus
week
age
signific
gross
histopatholog
lesion
observ
ewe
fetus
viremia
detect
viru
viral
rna
recov
detect
tissu
ewe
fetus
ewe
inocul
signific
advers
clinic
event
observ
group
studi
ewe
pregnant
time
inocul
pregnant
ewe
singl
viabl
fetu
time
necropsi
three
fetus
cr
measur
cm
cm
cm
respect
estim
fetus
also
week
age
signific
gross
lesion
anomali
observ
ewe
fetus
vaccin
viru
recov
detect
serum
tissu
ewe
fetus
ewe
inocul
rvf
signific
advers
clinic
event
note
group
studi
studi
termin
anim
necropsi
ewe
dead
autolyz
fetu
measur
cm
cr
estim
fetu
approxim
week
gestat
pcr
analysi
brain
tissu
fetu
weakli
posit
vaccin
viral
rna
unabl
recov
viabl
viru
three
ewe
live
viabl
fetus
ewe
twin
measur
cm
cr
week
ewe
ewe
singl
fetu
measur
cm
cm
respect
week
viru
recov
detect
serum
tissu
ewe
fetus
ewe
inocul
signific
advers
clinic
event
observ
group
studi
howev
necropsi
ewe
dead
autolyz
fetu
cr
measur
cm
suggest
fetu
week
gestat
three
ewe
viabl
fetus
two
singl
fetus
one
twin
measur
cm
cr
indic
approxim
week
gestat
viremia
detect
viru
viral
rna
recov
detect
tissu
ewe
fetus
compar
weak
neutral
antibodi
respons
vaccin
caus
us
abandon
cultur
livestock
vaccin
candid
vaccin
show
rapid
vigor
serolog
respons
togeth
untoward
clinic
event
elect
perform
dose
escal
studi
vaccin
candid
determin
optimum
safe
immunogen
dose
anim
phase
termin
day
inocul
tabl
tabl
viru
titer
pfuml
determin
direct
plaqu
assay
detect
serum
ewe
day
pcr
analysi
recov
viru
amplif
vero
cell
show
partial
delet
segment
rna
sequenc
viru
done
contrast
viru
viral
rna
recov
three
ewe
termin
studi
prnt
titer
virem
ewe
higher
cohort
tabl
virem
ewe
pregnant
cm
retroperiton
abscess
observ
adher
uteru
larg
small
intestin
ewe
singl
morpholog
normal
viabl
fetu
cr
measur
cm
respect
estim
fetus
approxim
week
age
viru
viral
rna
recov
detect
tissu
ewe
fetus
necropsi
neutral
antibodi
found
fetal
sera
tabl
occur
ewe
necropsi
ewe
hematuria
dead
autolyz
fetu
cr
measur
cm
week
fetu
weakli
posit
viral
rna
liver
spleen
kidney
brain
tissu
unabl
isol
viru
tissu
advanc
post
mortem
autolysi
prevent
observ
definit
microscop
lesion
ewe
pregnant
ewe
live
morpholog
normal
fetus
base
cr
measur
viabl
fetus
estim
approxim
week
age
viremia
titer
pfuml
serum
detect
ewe
day
pcr
analysi
recov
viru
show
delet
segment
similar
vaccin
viru
necropsi
viru
viral
antigen
detect
tissu
dam
viabl
fetus
group
ewe
inocul
pfu
advers
clinic
event
occur
group
viremia
titer
pfu
ml
serum
detect
ewe
day
pcr
analysi
recov
viru
also
show
delet
segment
similar
input
viru
ewe
also
slightli
elev
rectal
temperatur
day
respect
temperatur
within
upper
rang
normal
day
necropsi
ewe
live
fetus
measur
cm
cr
ewe
twin
fetus
estim
fetus
week
age
viru
detect
organ
dam
fetus
ewe
markedli
lower
prnt
titer
ewe
end
studi
tabl
four
six
ewe
robust
serum
igg
respons
wherea
ewe
decidedli
lower
serum
igg
respons
ewe
mount
detect
serum
igg
respons
vaccin
ewe
temperatur
time
inocul
day
febril
temperatur
day
test
livestock
vaccin
candid
produc
alter
genom
agent
test
human
volunt
signific
advers
event
shown
safe
protect
virul
rvfv
challeng
livestock
includ
midto
lateterm
pregnant
sheep
rhesu
macaqu
phase
studi
reveal
littl
differ
prnt
respons
advers
event
abl
detect
viral
rna
one
two
dead
fetus
advanc
postmortem
autolysi
preclud
visual
definit
microscop
lesion
estim
age
dead
fetu
group
suggest
die
around
time
ewe
inocul
recov
viral
rna
autolyz
fetu
group
enough
amplifi
prenat
loss
livestock
due
earli
embryon
fetal
death
substanti
may
due
varieti
caus
combin
factor
often
caus
fetal
death
accur
determin
dose
escal
studi
focus
two
higher
dose
vaccin
number
test
anim
pfu
dose
increas
much
anim
space
would
permit
mark
differ
within
three
higher
dosag
group
one
anim
ewe
pfu
dose
group
develop
low
prnt
titer
vaccin
temperatur
sensit
perhap
elev
rectal
temperatur
time
inocul
pyrexia
day
contribut
poor
viru
replic
result
suppress
prnt
respons
lack
detect
igg
ewe
one
ewe
ewe
pfu
dose
group
develop
neutral
antibodi
titer
yet
statist
signific
differ
igg
respons
four
dosag
group
figur
differ
prnt
respons
phase
phase
ii
group
receiv
dose
vaccin
surpris
may
reflect
group
individu
variabl
signific
differ
mean
prnt
respons
although
unabl
allow
ewe
go
term
believ
euthan
ewe
day
gestat
suffici
time
allow
determin
age
health
morpholog
fetu
vaccin
recombin
viru
highli
immunogen
dose
pfu
found
safe
nonteratogen
inocul
ewe
earli
gestat
studi
suggest
viru
may
promis
candid
livestock
vaccin
genom
delet
may
prove
use
neg
marker
serolog
differenti
vaccin
anim
infect
anim
evalu
longterm
protect
immun
done
tabl
neutral
antibodi
respons
individu
ewe
phase
studi
anim
inocul
sc
pfu
respect
vaccin
candid
watermarktext
watermarktext
watermarktext
tabl
neutral
antibodi
respons
individu
ewe
phase
ii
group
studi
anim
receiv
pfu
sc
vaccin
candid
necropsi
ewe
pregnant
ewe
dead
partial
autolyz
fetu
pcr
product
consist
input
viru
recov
ewe
live
morpholog
normal
fetus
